Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lipid lowering drugs in diabetes: lipid lowering has ophthalmic benefits.

× No keyword cloud information.

5 in total

1. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Authors: A Keech; R J Simes; P Barter; J Best; R Scott; M R Taskinen; P Forder; A Pillai; T Davis; P Glasziou; P Drury; Y A Kesäniemi; D Sullivan; D Hunt; P Colman; M d'Emden; M Whiting; C Ehnholm; M Laakso
Journal: Lancet Date: 2005-11-26 Impact factor: 79.321

Review 2. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Authors: João Costa; Margarida Borges; Cláudio David; António Vaz Carneiro
Journal: BMJ Date: 2006-04-03

3. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.

Authors: Amod Gupta; Vishali Gupta; Shveta Thapar; Anil Bhansali
Journal: Am J Ophthalmol Date: 2004-04 Impact factor: 5.258

4. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

Authors: E Y Chew; M L Klein; F L Ferris; N A Remaley; R P Murphy; K Chantry; B J Hoogwerf; D Miller
Journal: Arch Ophthalmol Date: 1996-09

5. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more.

Authors: R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal: Arch Ophthalmol Date: 1989-02

5 in total

1 in total

1. Current concepts in intravitreal drug therapy for diabetic retinopathy.

Authors: Anant Pai; Maha M El Shafei; Osman A Z Mohammed; Mustafa Al Hashimi
Journal: Saudi J Ophthalmol Date: 2010-06-30

1 in total